| 李航顺梁兆光△.利钠肽在急性心力衰竭预后评估及指导治疗中的作用[J].,2012,12(26):5198-5200 |
| 利钠肽在急性心力衰竭预后评估及指导治疗中的作用 |
| Utility of Natriuretic Peptides Testing in the Evaluation and Managementof Acute Heart Failure |
| |
| DOI： |
| 中文关键词: 急性心衰 利钠肽 预后 治疗最优化 |
| 英文关键词: Acute heart failure Natriuretic peptide Prognosis Treatment therapy optimization |
| 基金项目: |
|
| 摘要点击次数: 599 |
| 全文下载次数: 825 |
| 中文摘要: |
| 利钠肽(BNP与NT-proBNP)是预测急性心衰预后及评估急性心衰治疗效果可靠的指标。日常临床决策加用利钠肽检测提
高了急性心衰高危患者的发现率，而这些患者往往需要加强追踪及强化治疗。现就利钠肽在评估急性心衰预后及指导心衰治疗
中的价值作如下综述。 |
| 英文摘要: |
| Natriuretic peptides(B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-pro-BNP))
are reliable tools for establishing prognosis and evaluating the effectiveness of treatment of acutely heart failure.The addition of BNP and
NT-proBNP to usual clinical decision making enhances detection of high-risk patients who need aggressive follow-up and adjustment of
treatment. we present an overview of the value of natriuretic peptides in the context of acute heart failure prognosis and treatment therapy
optimization. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
